These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26075427)

  • 1. A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma.
    Kao SC; Fulham M; Wong K; Cooper W; Brahmbhatt H; MacDiarmid J; Pattison S; Sagong JO; Huynh Y; Leslie F; Pavlakis N; Clarke S; Boyer M; Reid G; van Zandwijk N
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1467-9. PubMed ID: 26075427
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
    van Zandwijk N; Pavlakis N; Kao SC; Linton A; Boyer MJ; Clarke S; Huynh Y; Chrzanowska A; Fulham MJ; Bailey DL; Cooper WA; Kritharides L; Ridley L; Pattison ST; MacDiarmid J; Brahmbhatt H; Reid G
    Lancet Oncol; 2017 Oct; 18(10):1386-1396. PubMed ID: 28870611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Diffuse Intrapulmonary Malignant Mesothelioma.
    Kumazawa M; Arakawa H; Shiobara T; Ishii Y; Nakazato Y; Kaji Y
    J Thorac Imaging; 2019 Nov; 34(6):W147-W149. PubMed ID: 31658210
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma.
    Tsutani Y; Takuwa T; Miyata Y; Fukuoka K; Hasegawa S; Nakano T; Okada M
    Ann Oncol; 2013 Apr; 24(4):1005-10. PubMed ID: 23136224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study.
    Buikhuisen WA; Qayyum F; Armato SG; Baas P
    Lung Cancer; 2019 Dec; 138():139-140. PubMed ID: 31733933
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study.
    Gudmundsson E; Labby Z; Straus CM; Sensakovic WF; Li F; Rose B; Cunliffe A; Kindler HL; Armato SG
    Eur Radiol; 2019 Feb; 29(2):682-688. PubMed ID: 29967955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma.
    Kanemura S; Kuribayashi K; Funaguchi N; Shibata E; Mikami K; Doi H; Kitajima K; Hasegawa S; Nakano T
    Eur J Radiol; 2017 Jan; 86():92-98. PubMed ID: 28027772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant pleural mesothelioma in a young adult with no known exposure to asbestos.
    Espinosa Muñoz E; Ramírez Ocaña D; Gutiérrez Cardo AL
    Arch Bronconeumol; 2016 Dec; 52(12):615-616. PubMed ID: 27156205
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant mesothelioma with fungating masses and multiple sites involvement.
    Sim JK; Oh JY; Min KH; Hur GY; Shim JJ; Kang KH; Lee SY
    Clin Respir J; 2017 Jul; 11(4):524-528. PubMed ID: 26364960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastases in malignant pleural mesothelioma: a new radiological appearance.
    Fares M; Abbas O; Jamaleddine G; Bou-Khalil P
    Respirology; 2008 Sep; 13(5):746-7. PubMed ID: 18513248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of pleural epithelioid sarcoma of proximal type presenting as malignant pleural mesothelioma.
    Madsen GA; Rasmussen TR; Bærentzen S
    J Thorac Oncol; 2013 Oct; 8(10):e89-90. PubMed ID: 24457248
    [No Abstract]   [Full Text] [Related]  

  • 12. Not everything is what it seems: malignant pleural mesothelioma mimicking lung cancer.
    Prisciandaro E; Girelli L; Rampinelli C; Ghioni M; Spaggiari L
    Adv Respir Med; 2019; 87(6):265-267. PubMed ID: 31970729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural mesothelioma segmentation for photodynamic therapy planning.
    Brahim W; Mestiri M; Betrouni N; Hamrouni K
    Comput Med Imaging Graph; 2018 Apr; 65():79-92. PubMed ID: 28789867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of a malignant peritoneal mesothelioma in the forma of rough hepatic calcifications.
    Lara Romero C; Casado Bernabéu A; Romero Pérez E
    Rev Esp Enferm Dig; 2017 May; 109(5):374. PubMed ID: 28480727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of new flex-rigid pleuroscopy in the diagnosis of malignant pleural mesothelioma.
    Ishii S; Ishii Y; Kaburagi T; Nakano T
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30642855
    [No Abstract]   [Full Text] [Related]  

  • 16. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).
    Armato SG; Nowak AK
    J Thorac Oncol; 2018 Jul; 13(7):1012-1021. PubMed ID: 29753121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of computed tomography imaging and clinical prognosis of pleural mesothelioma].
    Zhu H; Zhou J; Yang R; Zhou N; Lü R
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(25):1970-2. PubMed ID: 25253013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Pleural Mesothelioma: Accuracy of CT Against Immunohistochemical Test Among the Mexican Population.
    Gopar-Nieto R; Aguilar-Madrid G; Sotelo-Martínez L; Juárez-Pérez CA; Kelly-García J; Argote-Greene L; Ochoa-Vázquez MD; García-Bazán EM; Ramírez-Pérez J; Haro-García L; Jiménez-Ramírez C; Cabello-López A
    Arch Med Res; 2015 Feb; 46(2):107-11. PubMed ID: 25707292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
    Hall DO; Hooper CE; Searle J; Darby M; White P; Harvey JE; Braybrooke JP; Maskell NA; Masani V; Lyburn ID
    Nucl Med Commun; 2018 Feb; 39(2):161-170. PubMed ID: 29300270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
    Kitajima K; Doi H; Kuribayashi K
    Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.